Clinical Trials

The purpose of this study is to investigate the clinical presentation, radiological findings, surgical treatment, and the subsequent clinical course and outcomes of cases of myelopathy associated with idiopathic/cryptogenic causes of spinal cord displacement who have been evaluated at Mayo Clinic.

The purpose of this study is to determine if there are any changes in handwriting of patients with cervical spondylotic myelopathy, and assess the value of handwriting changes as an early predictor in the disease.

CSM (Cervical spondylotic myelopathy) is the most common cause of spinal cord injury worldwide. While there is evidence from the recently completed SpineNet prospective study that surgical decompression is an effective treatment for CSM, it is clear that many patients have remaining neurological impairment. While surgery is relatively safe, approximately 3% of patients maintain a neurological problem. Given this background and data from preclinical models of non-traumatic and traumatic spinal cord injury, there is strong evidence to consider the potential benefit of adding a neuroprotective drug which aids in the treatment of patients with CSM whom are undergoing surgical decompression. ...

The objective of this study is to develop a clinical registry of patients diagnosed with cervical radiculopathy or cervical myelopathy over a 3 year period.

The purpose of this study is to examine the role of an Early Recovery After Surgery (ERAS) protocol designed for posterior cervical spinal fusion.

The purpose of this study is to establish a repository consisting of clinical information, radiological data, serum, peripheral blood lymphocytes, plasma, cerebrospinal fluid (CSF), urine, stool, DNA and tissue specimens collected from patients who have central nervous system (CNS)  inflammatory diseases.